FDA Inspection 1271861 — Andrzej Lewinski, MD, Ph.D.

Andrzej Lewinski, MD, Ph.D. — FEI 3033042744

The FDA completed an inspection of Andrzej Lewinski, MD, Ph.D. on Mar 14, 2025 in Lodz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.